tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Luke Sergott, 135 are a HOLD (27.16%), 298 are a BUY (59.96%), 64 are a SELL (12.88%).
Analyst Luke Sergott, currently employed at BARCLAYS, carries an average stock price target met ratio of 73.61% that have a potential upside of 13.85% achieved within 128 days.
Luke Sergott’s has documented 1,003 price targets and ratings displayed on 31 stocks. The coverage is on Basic Materials, Healthcare, Industrials sectors.
Most recent stock forecast was given on CRL, Charles River Laboratories at 25-Sep-2026.
Analyst best performing recommendations are on PACB (PACIFIC BIOSCIENCES OF CALIFORNIA).
The best stock recommendation documented was for SHC (SOTERA HEALTH CO) at 11/15/2022. The price target of $6 was fulfilled within 2 days with a profit of $0.97 (13.92%) receiving and performance score of 69.58.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 04-Aug-2025
$16
$0.66 (4.30%)
27 days ago
(09-Sep-2026)
8/12 (66.67%)
$1.12 (7.53%)
147
Hold Since 04-Aug-2025
$14
$-1.34 (-8.74%)
$12
2 months 6 days ago
(30-Jul-2026)
11/19 (57.89%)
$0.14 (1.01%)
99
Hold Since 04-Aug-2025
$15
$-0.34 (-2.22%)
$12
2 months 6 days ago
(30-Jul-2026)
9/13 (69.23%)
$1.14 (8.23%)
53
Buy Since 11-Jun-2019
$16
$0.66 (4.30%)
$14
2 months 6 days ago
(30-Jul-2026)
4/10 (40%)
$2.14 (15.44%)
206
Hold Since 06-Apr-2026
$14
$-1.34 (-8.74%)
$10.5
2 months 6 days ago
(30-Jul-2026)
11/16 (68.75%)
$0.14 (1.01%)
39
Which stock is Luke Sergott most bullish on?
Which stock is Luke Sergott most reserved on?
What Year was the first public recommendation made by Luke Sergott?
